Cargando…

Efficacy of Smartphone Apps in Patients With Depressive Disorders: A Systematic Review

BACKGROUND: Digital interventions have become an accessible format in clinical practice to provide better support for patients with mental disorders. However, the clinical efficacy in patients with depressive disorders is not well known. We aimed to determine the efficacy of smartphone applications...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Gómez, Alba, Valdés-Florido, María José, Lahera, Guillermo, Andrade-González, Nelson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411805/
https://www.ncbi.nlm.nih.gov/pubmed/36032248
http://dx.doi.org/10.3389/fpsyt.2022.871966
Descripción
Sumario:BACKGROUND: Digital interventions have become an accessible format in clinical practice to provide better support for patients with mental disorders. However, the clinical efficacy in patients with depressive disorders is not well known. We aimed to determine the efficacy of smartphone applications (apps) in patients diagnosed with a depressive disorder. METHOD: An electronic database search was performed of PubMed, PsycINFO, and Web of Science, to identify relevant articles up to June 12, 2021. Peer-reviewed articles were screened and selected based on predetermined inclusion and exclusion criteria. RESULTS: Seven articles met the inclusion criteria and therefore were selected for the systematic review, which included a total of 651 patients. The results were heterogeneous, essentially due to the different methodologies used in the selected studies. CONCLUSIONS: Digital smartphone-delivered interventions do not appear to reduce depressive symptomatology nor improve the quality of life in patients diagnosed with depressive disorders when compared to an active control group. Taking into account the inherent methodological difficulties and the variability among such studies, it is apparent that further research—with more methodologically refined clinical trials, including larger sample sizes—is needed.